Matt Zuga - Net Worth and Insider Trading
Matt Zuga Net Worth
The estimated net worth of Matt Zuga is at least $3 Million dollars as of 2024-04-29. Matt Zuga is the Director of TELA Bio Inc and owns about 514,481 shares of TELA Bio Inc (TELA) stock worth over $2 Million. Matt Zuga is also the CFO & Chief Business Officer of Acumen Pharmaceuticals Inc and owns about 211,445 shares of Acumen Pharmaceuticals Inc (ABOS) stock worth over $670,281. Details can be seen in Matt Zuga's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Matt Zuga has not made any transactions after 2024-01-18 and currently still holds the listed stock(s).
Transaction Summary of Matt Zuga
Matt Zuga Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matt Zuga owns 5 companies in total, including Elutia Inc (ELUT) , HighCape Capital Acquisition Corp (CAPAU) , and TELA Bio Inc (TELA) among others .
Click here to see the complete history of Matt Zuga’s form 4 insider trades.
Insider Ownership Summary of Matt Zuga
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELUT | Elutia Inc | 2020-10-07 | director & 10 percent owner |
| CAPAU | HighCape Capital Acquisition Corp | 2020-09-03 | director & 10 percent owner |
| TELA | TELA Bio Inc | 2019-11-08 | director |
| ABOS | Acumen Pharmaceuticals Inc | 2024-01-18 | Chief Financial Officer |
| QSI | Quantum-Si Inc | 2020-09-03 | director & 10 percent owner |
Matt Zuga Latest Holdings Summary
Matt Zuga currently owns a total of 2 stocks. Among these stocks, Matt Zuga owns 514,481 shares of TELA Bio Inc (TELA) as of November 8, 2019, with a value of $2 Million and a weighting of 77.35%. Matt Zuga also owns 211,445 shares of Acumen Pharmaceuticals Inc (ABOS) as of January 18, 2024, with a value of $670,281 and a weighting of 22.65%.
Latest Holdings of Matt Zuga
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TELA | TELA Bio Inc | 2019-11-08 | 514,481 | 4.45 | 2,289,440 |
| ABOS | Acumen Pharmaceuticals Inc | 2024-01-18 | 211,445 | 3.17 | 670,281 |
Holding Weightings of Matt Zuga
Matt Zuga Form 4 Trading Tracker
According to the SEC Form 4 filings, Matt Zuga has made a total of 1 transactions in TELA Bio Inc (TELA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in TELA Bio Inc is the acquisition of 86,121 shares on November 8, 2019, which cost Matt Zuga around $1 Million.
According to the SEC Form 4 filings, Matt Zuga has made a total of 1 transactions in Acumen Pharmaceuticals Inc (ABOS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Acumen Pharmaceuticals Inc is the sale of 4,242 shares on January 18, 2024, which brought Matt Zuga around $15,738.
Insider Trading History of Matt Zuga
- 1
Matt Zuga Trading Performance
GuruFocus tracks the stock performance after each of Matt Zuga's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matt Zuga is 14.23%. GuruFocus also compares Matt Zuga's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matt Zuga within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matt Zuga's insider trading performs compared to the benchmark.
Performance of Matt Zuga
Average Return
22.32%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.34 | 14.23 | -11.09 | 22.32 | -2.38 | -18.89 |
| Relative Return to S&P 500(%) | -9.05 | 6.64 | -5.81 | 8.86 | -25.64 | -26.25 |
Matt Zuga Ownership Network
Ownership Network List of Matt Zuga
Ownership Network Relation of Matt Zuga
Matt Zuga Owned Company Details
What does Elutia Inc do?
Who are the key executives at Elutia Inc?
Matt Zuga is the director & 10 percent owner of Elutia Inc. Other key executives at Elutia Inc include 10 percent owner Elutia Pipe Investment, Lp , 10 percent owner Birchview Fund Llc , and Chief Commercial Officer Thomas Englese .
Elutia Inc (ELUT) Insider Trades Summary
Over the past 18 months, Matt Zuga made no insider transaction in Elutia Inc (ELUT). Other recent insider transactions involving Elutia Inc (ELUT) include a net purchase of 377,261 shares made by Birchview Fund Llc , a net purchase of 735,000 shares made by Highcape Capital, L.p. , and a net purchase of 28,000 shares made by Matthew Ferguson .
In summary, during the past 3 months, insiders sold 0 shares of Elutia Inc (ELUT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289 shares of Elutia Inc (ELUT) were sold and 1,145,359 shares were bought by its insiders, resulting in a net purchase of 1,145,070 shares.
Elutia Inc (ELUT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elutia Inc Insider Transactions
Matt Zuga Mailing Address
Above is the net worth, insider trading, and ownership report for Matt Zuga. You might contact Matt Zuga via mailing address: C/o Tela Bio, Inc., 1 Great Valley Parkway, Suite 24, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
